litlas
ログインアカウント作成

Nicholas C. Turner

1989–2025 年に発表

181
論文数
42,345
被引用数
89
h 指数
169
i10 指数

被引用数

Nicholas C. Turner の年別被引用数1964 年: 被引用 4 件1971 年: 被引用 1 件1990 年: 被引用 8 件1991 年: 被引用 4 件1992 年: 被引用 13 件1993 年: 被引用 6 件1994 年: 被引用 3 件1995 年: 被引用 10 件1996 年: 被引用 6 件1997 年: 被引用 9 件1998 年: 被引用 9 件1999 年: 被引用 6 件2000 年: 被引用 8 件2001 年: 被引用 12 件2002 年: 被引用 10 件2003 年: 被引用 7 件2004 年: 被引用 9 件2005 年: 被引用 15 件2006 年: 被引用 38 件2007 年: 被引用 75 件2008 年: 被引用 129 件2009 年: 被引用 130 件2010 年: 被引用 263 件2011 年: 被引用 223 件2012 年: 被引用 227 件2013 年: 被引用 265 件2014 年: 被引用 214 件2015 年: 被引用 279 件2016 年: 被引用 387 件2017 年: 被引用 489 件2018 年: 被引用 513 件2019 年: 被引用 1,738 件2020 年: 被引用 2,018 件2021 年: 被引用 2,137 件2022 年: 被引用 1,901 件2023 年: 被引用 1,649 件2024 年: 被引用 2,505 件2025 年: 被引用 1,543 件2026 年: 被引用 45 件1965〜1970 年は被引用が無いため表示していません1972〜1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,388 件、この内訳の 23.4%中国: 引用元論文 2,182 件、この内訳の 11.7%イギリス: 引用元論文 1,524 件、この内訳の 8.1%イタリア: 引用元論文 1,202 件、この内訳の 6.4%ドイツ: 引用元論文 871 件、この内訳の 4.7%フランス: 引用元論文 783 件、この内訳の 4.2%スペイン: 引用元論文 717 件、この内訳の 3.8%カナダ: 引用元論文 607 件、この内訳の 3.2%日本: 引用元論文 524 件、この内訳の 2.8%オーストラリア: 引用元論文 510 件、この内訳の 2.7%オランダ: 引用元論文 466 件、この内訳の 2.5%韓国: 引用元論文 382 件、この内訳の 2%
0%23.4%その他 24.5%

機関

分野

  • Medicine49.6%
  • Biochemistry, Genetics and Molecular Biology45.6%
  • Computer Science1.1%
  • Immunology and Microbiology0.9%
  • Engineering0.7%
  • Chemistry0.5%
  • その他1.6%

トピック

  • Advanced Breast Cancer Therapies7.3%
  • Cancer Genomics and Diagnostics6.9%
  • Cancer-related Molecular Pathways4.4%
  • Breast Cancer Treatment Studies3.8%
  • HER2/EGFR in Cancer Research3.6%
  • PARP inhibition in cancer therapy3.6%
  • その他70.4%

共著者

全論文

検索で開く
  1. ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

    著者: Alessandra Gennari, Fabrice André, Carlos H. Barrios, Javier Cortés, Evandro de Azambuja, A. DeMichele, Rebecca Dent, Deborah Fenlon, Joseph Gligorov, Sara A. Hurvitz, Seock‐Ah Im, David Krug, Wolfgang G. Kunz, Sherene Loi, Frédérique Penault‐Llorca, Jens Ricke, Mark E. Robson, Hope S. Rugo, Cristina Saura, Peter Schmid, Christian F. Singer, Tanja Španić, Sara M. Tolaney, Nicholas C. Turner, Giuseppe Curigliano, Sibylle Loibl, Shani Paluch–Shimon, Nadia Harbeck - Annals of Oncology 2021 被引用: 1,367

  2. Capivasertib in Hormone Receptor–Positive Advanced Breast Cancer

    著者: Nicholas C. Turner, Mafalda Oliveira, Sacha J. Howell, Florence Dalenc, Javier Cortés, Henry Gómez, Xichun Hu, Komal Jhaveri, Petr Krivorotko, Sibylle Loibl, Serafin Morales Murillo, Meena Okera, Yeon Hee Park, Joohyuk Sohn, Masakazu Toi, Eriko Tokunaga, Samih Yousef, Lyudmila Zhukova, Elza C. de Bruin, Lynda Grinsted, Gaia Schiavon, Andrew Foxley, Hope S. Rugo - New England Journal of Medicine 2023 被引用: 704

  3. ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group

    著者: Javier Pascual, Gerhardt Attard, François‐Clément Bidard, Giuseppe Curigliano, Leticia De Mattos‐Arruda, Maximilian Diehn, Antoîne Italiano, Johan Lindberg, Jason D. Merker, Clara Montagut, Nicola Normanno, Klaus Pantel, George Pentheroudakis, Sanjay Popat, Jorge S. Reis‐Filho, Jeanne Tie, Joan Seoane, N. Tarazona, Takayuki Yoshino, Nicholas C. Turner - Annals of Oncology 2022 被引用: 664

  4. The history and future of targeting cyclin-dependent kinases in cancer therapy

    著者: Uzma Asghar, Agnieszka K. Witkiewicz, Nicholas C. Turner, Erik S. Knudsen - Nature Reviews Drug Discovery 2015 被引用: 1,762

  5. Fibroblast growth factor signalling: from development to cancer

    著者: Nicholas C. Turner, Richard Grose - Nature reviews. Cancer 2010 被引用: 2,674

  6. Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial

    著者: Massimo Cristofanilli, Nicholas C. Turner, Igor Bondarenko, Jungsil Ro, Seock‐Ah Im, Norikazu Masuda, Marco Colleoni, Angela DeMichele, Sherene Loi, Sunil Verma, Hiroji Iwata, Nadia Harbeck, Ke Zhang, Kathy Puyana Theall, Yuqiu Jiang, Cynthia Huang Bartlett, María Koehler, Dennis J. Slamon - The Lancet Oncology 2016 被引用: 1,822

  7. Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer

    著者: Nicholas C. Turner, Dennis J. Slamon, Jungsil Ro, Igor Bondarenko, Seock‐Ah Im, Norikazu Masuda, Marco Colleoni, Angela DeMichele, Sherene Loi, Sunil Verma, Hiroji Iwata, Nadia Harbeck, Sibylle Loibl, Fabrice André, Kathy Puyana Theall, Xin Huang, C. Giorgetti, Cynthia Huang Bartlett, Massimo Cristofanilli - New England Journal of Medicine 2018 被引用: 1,293

  8. Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer

    著者: Nicholas C. Turner, Jungsil Ro, Fabrice André, Sherene Loi, Sunil Verma, Hiroji Iwata, Nadia Harbeck, Sibylle Loibl, Cynthia Huang Bartlett, Ke Zhang, C. Giorgetti, Sophia Randolph, María Koehler, Massimo Cristofanilli - New England Journal of Medicine 2015 被引用: 1,586

  9. Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor–Positive Breast Cancer

    著者: María Teresa Herrera-Abreu, Marta Palafox, Uzma Asghar, Martín A. Rivas, Rosalind Cutts, Isaac García-Murillas, Alex Pearson, Marta Guzmán, Olga Rodríguez, Judit Grueso, Meritxell Bellet, Javier Cortés, Richard Elliott, Sunil Pancholi, Christopher J. Lord, José Baselga, Mitch Dowsett, Lesley‐Ann Martin, Nicholas C. Turner, Violeta Serra - Cancer Research 2016 被引用: 779

  10. Treating cancer with selective CDK4/6 inhibitors

    著者: Ben O’Leary, Richard S. Finn, Nicholas C. Turner - Nature Reviews Clinical Oncology 2016 被引用: 1,157

  11. Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer

    著者: Isaac García-Murillas, Gaia Schiavon, Britta Weigelt, Charlotte K.Y. Ng, Sarah Hrebien, Rosalind Cutts, Maggie C.U. Cheang, Peter Osin, Ashutosh Nerurkar, Iwanka Kozarewa, Javier Armisen Garrido, Mitch Dowsett, Jorge S. Reis‐Filho, Ian E. Smith, Nicholas C. Turner - Science Translational Medicine 2015 被引用: 1,132

  12. The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial

    著者: Ben O’Leary, Rosalind Cutts, Yuan Liu, Sarah Hrebien, Xin Huang, Kerry Fenwick, Fabrice André, Sibylle Loibl, Sherene Loi, Isaac García-Murillas, Massimo Cristofanilli, Cynthia Huang Bartlett, Nicholas C. Turner - Cancer Discovery 2018 被引用: 667

  13. Advances and challenges in targeting FGFR signalling in cancer

    著者: Irina S. Babina, Nicholas C. Turner - Nature reviews. Cancer 2017 被引用: 796

  14. Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study

    著者: Hope S. Rugo, Florence Lerebours, Eva Ciruelos, Pamela Drullinsky, Manuel Ruíz‐Borrego, Patrick Neven, Yeon Hee Park, Aleix Prat, Thomas Bachelot, Dejan Juric, Nicholas C. Turner, Nickolas A. Sophos, Juan Pablo Zarate, Christina Arce, Yu-Ming Shen, Stuart Turner, Hemanth Kanakamedala, Wei‐Chun Hsu, Stephen Chia - The Lancet Oncology 2021 被引用: 349

  15. Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial

    著者: Eric P. Winer, Oleg Lipatov, Seock‐Ah Im, Anthony Gonçalvès, Eva Muñoz‐Couselo, Keun Seok Lee, Peter Schmid, Kenji Tamura, Laura Testa, Isabell Witzel, Shoichiro Ohtani, Nicholas C. Turner, Stefania Zambelli, Nadia Harbeck, Fabrice André, Rebecca Dent, Xuan Zhou, Vassiliki Karantza, Jaime Mejia, Javier Cortés - The Lancet Oncology 2021 被引用: 493

  16. Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review

    著者: Jason D. Merker, Geoffrey R. Oxnard, Carolyn C. Compton, Maximilian Diehn, Patricia A. Hurley, Alexander J. Lazar, Neal Lindeman, Christina M. Lockwood, Alex J. Rai, Richard L. Schilsky, Apostolia M. Tsimberidou, Patricia Vasalos, Brooke L. Billman, Thomas K. Oliver, Suanna S. Bruinooge, Daniel F. Hayes, Nicholas C. Turner - Archives of Pathology & Laboratory Medicine 2018 被引用: 929

  17. Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer

    著者: Isaac García-Murillas, Neha Chopra, Iñaki Comino‐Méndez, Matthew Beaney, Holly Tovey, Rosalind Cutts, Claire Swift, Divya Kriplani, Maria Afentakis, Sarah Hrebien, Giselle Walsh-Crestani, Peter Barry, Stephen Johnston, Alistair Ring, Judith M. Bliss, Simon Russell, Abigail Evans, Anthony Skene, Duncan Wheatley, Mitch Dowsett, Ian E. Smith, Nicholas C. Turner - JAMA Oncology 2019 被引用: 428

  18. Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer

    著者: Nicholas C. Turner, Claire Swift, Ben Jenkins, Lucy Kilburn, Maria Coakley, Matthew Beaney, Lisa Fox, Kate Goddard, Isaac García-Murillas, Paula Proszek, Peter S Hall, Catherine Harper‐Wynne, Tamas Hickish, Sarah Kernaghan, Iain R. Macpherson, Alicia Okines, Carlo Palmieri, Sophie Perry, Kat Randle, Claire Snowdon, Hilary Stobart, Andrew Wardley, Duncan Wheatley, Simon Waters, Matthew Winter, Michael Hubank, Steven Allen, Judith M. Bliss, Shing Leng Chan, Anne Armstrong, F. Raja, Peter Schmid, Andrew Tutt, René L. Roux, Susan Cleator - Annals of Oncology 2022 被引用: 191

  19. Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial

    著者: Peter Schmid, Jacinta Abraham, Stephen Chan, Duncan Wheatley, Adrian Murray Brunt, Gia Nemsadze, Richard D. Baird, Yeon Hee Park, Peter S Hall, Timothy Perren, Robert C. Stein, László Mangel, Jean-­Marc Ferrero, Melissa Phillips, John Conibear, Javier Cortés, Andrew Foxley, Elza C. de Bruin, Robert McEwen, Daniel Stetson, Brian Dougherty, Shah‐Jalal Sarker, Aaron Prendergast, Max McLaughlin-Callan, Matthew Burgess, Cheryl Lawrence, Hayley Cartwright, Kelly Mousa, Nicholas C. Turner - Journal of Clinical Oncology 2019 被引用: 389

  20. The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment

    著者: Laura Morrison, Sibylle Loibl, Nicholas C. Turner - Nature Reviews Clinical Oncology 2023 被引用: 246

  21. Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future

    著者: Laura M. Spring, Seth A. Wander, Fabrice André, Beverly Moy, Nicholas C. Turner, Aditya Bardia - The Lancet 2020 被引用: 466

  22. Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial

    著者: Nicholas C. Turner, Belinda Kingston, Lucy Kilburn, Sarah Kernaghan, Andrew Wardley, Iain R. Macpherson, Richard D. Baird, Rebecca Roylance, Peter Stephens, Olga Oikonomidou, Jeremy Braybrooke, Mark Tuthill, Jacinta Abraham, Matthew Winter, Hannah Bye, Michael Hubank, Heidrun Gevensleben, Ros Cutts, Claire Snowdon, Daniel Rea, David Cameron, Abeer M. Shaaban, Katrina Randle, Sue Martin, Katie Wilkinson, Laura Moretti, Judith M. Bliss, Alistair Ring - The Lancet Oncology 2020 被引用: 352

  23. Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer

    著者: Nicholas C. Turner, Seock‐Ah Im, Cristina Saura, Dejan Juric, Sibylle Loibl, Kevin Kalinsky, Peter Schmid, Sherene Loi, Patrapim Sunpaweravong, Antonino Musolino, Huiping Li, Qingyuan Zhang, Zbigniew Nowecki, Roland Leung, Eirini Thanopoulou, Noopur Shankar, Guiyuan Lei, Thomas J. Stout, Katherine E. Hutchinson, Jennifer L. Schutzman, Chunyan Song, Komal Jhaveri - New England Journal of Medicine 2024 被引用: 237

  24. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023

    著者: Giuseppe Curigliano, Harold J. Burstein, Michael Gnant, Sibylle Loibl, David Cameron, Meredith M. Regan, Carsten Denkert, Philip Poortmans, William P. Weber, Beat Thürlimann, Stefan Aebi, Meteb Al‐Foheidi, Fabrice André, Mykola Anikusko, R. Badwe, A.V. Barrio, Carlos H. Barrios, Jonas Bergh, Hervé Bonnefoi, Daniela Morales, Sara Y. Brucker, Harold J. Burstein, Carlos Caldas, David Cameron, F. Cardoso, Maria João Cardoso, L.A Carey, Stephen Chia, Charlotte E. Coles, J. Cortes, Giuseppe Curigliano, Jana de Boniface, Suzette Delaloge, A. DeMichele, Carsten Denkert, Gerd Fastner, Florian Fitzal, Prudence A. Francis, H Gamal, Oreste ­Gentilini, Michael Gnant, William J. Gradishar, B. Gulluoglu, Nadia Harbeck, Jörg Heil, Chien Shiun Huang, Jens Huober, Zeping Jiang, Orit Kaidar‐Person, Marleen Kok, Eun‐So Lee, Sherene Loi, S. Loibl, Miguel Martín, Icro Meattini, Monica Morrow, A. H. Partridge, Frédérique Penault‐Llorca, Martine Piccart, Lori J. Pierce, Philip Poortmans, Meredith M. Regan, J. S. Reis-Filho, Isabel T. Rubio, Hope S. Rugo, Emiel J. Rutgers, Cristina Saura, Elżbieta Senkus, Zhi-Ming Shao, Christian F. Singer, Tanja Španič, Beat Thuerlimann, Masakazu Toi, Sara M. Tolaney, Nicholas C. Turner, Andrew Tutt, M.-J. Vrancken Peeters, Toru Watanabe, William P. Weber, Hans Wildiers, B. Xu - Annals of Oncology 2023 被引用: 221